Conference Material
|
Slide Presentation
Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis
Arana B
View HTML
View PDF
Share
Download
Download
View HTML
View PDF
Share
Similar Content
Loading...
Loading...
Loading...
Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis | Conference Material / Slide Presentation | MSF Science Portal
Countries
Colombia
Peru
Subject Area
neglected tropical diseases
cutaneous leishmaniasis
Languages
English
DOI
10.7490/f1000research.1117902.1
Published Date
13 May 2020
Conference
MSF Scientific Days International 2020: Research
Dimensions Badge
